Le Lézard
Classified in: Health
Subjects: CHI, POL, AVO, MAT

Florida Legislators Consider Severely Limiting Pediatric Access to Medical Marijuana


TAMPA, Fla., March 9, 2021 /PRNewswire/ -- Despite overwhelming public support for medical cannabis, Florida legislators have put forth a bill (HB1455) to drastically restrict access for pediatric patients.

Under current law, qualified pediatric patients may be certified if two doctors concur the child is eligible and the risks outweigh the benefits. Neither of these doctors must be a pediatrician; however, families often seek one of the state's few pediatric medical cannabis specialists because of unique concerns of children ingesting marijuana.

Under the proposed law, even if the certifying physician is a board-certified pediatrician, the concurring physician must also be a board-certified pediatrician. This would make it significantly more difficult for parents and caregivers to access their child's medicine. 

According to Dr. David Berger, a board-certified Tampa pediatrician specializing in pediatric medical cannabis:

There are very few Florida pediatricians experienced in treating pediatric medical cannabis patients or willing to confirm a child's eligibility. If the certifying doctor is a board-certified pediatrician, there is no reason the second physician needs to also be a board-certified pediatrician. Not all families have access to a board-certified pediatrician, which means children will not get the medication they need.

Dr. Berger is the Founder and Medical Director of Wholistic ReLeaf, one of Florida's only clinics specializing in pediatric medical cannabis. 

The proposed law would also drastically reduce the level of THC permitted in concentrated inhaled oils   If enacted, children would need to vaporize larger, more frequent quantities of oil to effectively treat their conditions. This could be detrimental to both physical and behavioral health, especially for children who have seizures or are on the neurodevelopmental spectrum.

Legislators will meet Tuesday, March 9, 9:30 am ET.  Dr. Berger is working with concerned parents and colleagues to lead the fight against the bill. He encourages all concerned Floridians to contact their state legislators.

Dr. Berger will be available for comment beginning 5:00 pm, March 9th, after the committee meeting.

MEDIA CONTACT:

Whitley Procopio
[email protected]
c: (727) 902-0748

 

SOURCE Wholistic ReLeaf


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: